Abbott Laboratories vs. Rhythm Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$109.29 -1.06%
VS RYTMRhythm Pharmaceuticals, Inc. Common Stock
$112.16 -1.57%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | RYTM | |
|---|---|---|
| Market Cap | $189.28 billion | $7.90 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | RYTM | |
|---|---|---|
| Dividend Yield | 2.31% | — |
ABT and RYTM split the dividend factors evenly.
Risk & Sentiment
| ABT | RYTM | |
|---|---|---|
| Short Interest | 0.57% | 1.11% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, RYTM overview, RYTM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.